New drug combo targets Hard-to-Treat cancers in early trial

NCT ID NCT05981703

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study is testing a new drug called BGB-26808, either alone or with another drug (tislelizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goal is to find a safe dose and check for side effects. About 217 participants will take part across multiple centers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BGB-26808 (HPK1 inhibitor) and tislelizumab (anti-PD-1 antibody)

What this could lead to

If successful, this could lead to a new treatment option for people with advanced solid tumors that have stopped responding to other therapies.

What could go wrong

This is an early Phase 1 trial focused on safety and dosing, so it is too soon to know if the drug will work. Side effects are possible, and the drug may not shrink tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Auckland City Hospital

    RECRUITING

    Auckland, 1023, New Zealand

  • City of Hope National Medical Center

    RECRUITING

    Duarte, California, 91010-3012, United States

  • Hangzhou First Peoples Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310006, China

  • Harbin Medical University Cancer Hospital

    RECRUITING

    Harbin, Heilongjiang, 150000, China

  • Harbour Cancer and Wellness

    RECRUITING

    Auckland, 1023, New Zealand

  • Health New Zealand Te Whatu Ora Lakes Rotorua Hospital

    RECRUITING

    Rotorua, 3010, New Zealand

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, 430079, China

  • Icahn School of Medicine At Mount Sinai

    RECRUITING

    New York, New York, 10029-6504, United States

  • Icon Cancer Centre Kurralta Park

    RECRUITING

    Kurralta Park, South Australia, SA 5037, Australia

  • Jining No1 Peoples Hospital West Branch

    RECRUITING

    Jining, Shandong, 272000, China

  • John Theurer Cancer Center Hackensack University Medical Center

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Linear Clinical Research

    RECRUITING

    Nedlands, Western Australia, WA 6009, Australia

  • Macquarie University

    RECRUITING

    North Ryde, New South Wales, NSW 2109, Australia

  • Providence Portland Medical Center

    RECRUITING

    Portland, Oregon, 97213-2933, United States

  • Shanghai East Hospital Branch Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200123, China

  • Shanghai Pulmonary Hospital

    COMPLETED

    Shanghai, Shanghai Municipality, 200433, China

  • Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital

    RECRUITING

    Chengdu, Sichuan, 610071, China

  • Southside Cancer Care

    COMPLETED

    Miranda, New South Wales, NSW 2228, Australia

  • Sylvester Cancer Center, University of Miami

    RECRUITING

    Miami, Florida, 33136, United States

  • Taizhou Hospital of Zhejiang Province (East)

    COMPLETED

    Taizhou, Zhejiang, 317004, China

  • The First Affiliated Hospital of Anhui Medical Universitygaoxin Branch

    RECRUITING

    Hefei, Anhui, 230022, China

  • The First Hospital of China Medical University Hunnan Branch

    RECRUITING

    Shenyang, Liaoning, 110167, China

  • The University of Texas Md Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030-4009, United States

  • Tongji Hospital,Tongji Medical College of Hustsino French New City Branch

    RECRUITING

    Wuhan, Hubei, 430101, China

  • University of Michigan Health System

    RECRUITING

    Ann Arbor, Michigan, 48109-5316, United States

  • University of Southern California Norris Comprehensive

    RECRUITING

    Los Angeles, California, 90033, United States

  • Yale University Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06520-8028, United States

  • Yantai Yuhuangding Hospital

    RECRUITING

    Yantai, Shandong, 264000, China